Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP379576.RAaiQmVRLHmgG1q6mZEf66EbnTKvrZrFXDUcCw9Ciu3UQ130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP379576.RAaiQmVRLHmgG1q6mZEf66EbnTKvrZrFXDUcCw9Ciu3UQ130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP379576.RAaiQmVRLHmgG1q6mZEf66EbnTKvrZrFXDUcCw9Ciu3UQ130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP379576.RAaiQmVRLHmgG1q6mZEf66EbnTKvrZrFXDUcCw9Ciu3UQ130_provenance.
- NP379576.RAaiQmVRLHmgG1q6mZEf66EbnTKvrZrFXDUcCw9Ciu3UQ130_assertion description "[The anti-HER2 antibody trastuzumab has shown significant clinical benefits in metastatic breast cancer; however, resistance to trastuzumab is common.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP379576.RAaiQmVRLHmgG1q6mZEf66EbnTKvrZrFXDUcCw9Ciu3UQ130_provenance.
- NP379576.RAaiQmVRLHmgG1q6mZEf66EbnTKvrZrFXDUcCw9Ciu3UQ130_assertion evidence source_evidence_literature NP379576.RAaiQmVRLHmgG1q6mZEf66EbnTKvrZrFXDUcCw9Ciu3UQ130_provenance.
- NP379576.RAaiQmVRLHmgG1q6mZEf66EbnTKvrZrFXDUcCw9Ciu3UQ130_assertion SIO_000772 24838231 NP379576.RAaiQmVRLHmgG1q6mZEf66EbnTKvrZrFXDUcCw9Ciu3UQ130_provenance.
- NP379576.RAaiQmVRLHmgG1q6mZEf66EbnTKvrZrFXDUcCw9Ciu3UQ130_assertion wasDerivedFrom befree-20150227 NP379576.RAaiQmVRLHmgG1q6mZEf66EbnTKvrZrFXDUcCw9Ciu3UQ130_provenance.
- NP379576.RAaiQmVRLHmgG1q6mZEf66EbnTKvrZrFXDUcCw9Ciu3UQ130_assertion wasGeneratedBy ECO_0000203 NP379576.RAaiQmVRLHmgG1q6mZEf66EbnTKvrZrFXDUcCw9Ciu3UQ130_provenance.
- befree-20150227 importedOn "2015-02-27" NP379576.RAaiQmVRLHmgG1q6mZEf66EbnTKvrZrFXDUcCw9Ciu3UQ130_provenance.